Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Heart Circ Physiol ; 293(1): H784-9, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17468334

ABSTRACT

Local cooling (LC) causes a cutaneous vasoconstriction (VC). In this study, we tested whether there is a mechanism that links LC to VC nerve function via sensory nerves. Six subjects participated. Local skin and body temperatures were controlled with Peltier probe holders and water-perfused suits, respectively. Skin blood flow at four forearm sites was monitored by laser-Doppler flowmetry with the following treatments: untreated control, pretreatment with local anesthesia (LA) blocking sensory nerve function, pretreatment with bretylium tosylate (BT) blocking VC nerve function, and pretreatment with both LA and BT. Local skin temperature was slowly reduced from 34 to 29 degrees C at all four sites. Both sites treated with LA produced an increase in cutaneous vascular conductance (CVC) early in the LC process (64 +/- 55%, LA only; 42 +/- 14% LA plus BT; P < 0.05), which was absent at the control and BT-only sites (5 +/- 8 and 6 +/- 8%, respectively; P > 0.05). As cooling continued, there were significant reductions in CVC at all sites (P < 0.05). At control and LA-only sites, CVC decreased by 39 +/- 4 and 46 +/- 8% of the original baseline values, which were significantly (P < 0.05) more than the reductions in CVC at the sites treated with BT and BT plus LA (-26 +/- 8 and -22 +/- 6%). Because LA affected only the short-term response to LC, either alone or in the presence of BT, we conclude that sensory nerves are involved early in the VC response to LC, but not for either adrenergic or nonadrenergic VC with longer term LC.


Subject(s)
Afferent Pathways/physiology , Body Temperature Regulation/physiology , Sensation/physiology , Skin Temperature/physiology , Skin/blood supply , Skin/innervation , Vasoconstriction/physiology , Blood Flow Velocity/physiology , Cold Temperature , Female , Humans , Male
2.
Circ Res ; 96(4): 398-400, 2005 Mar 04.
Article in English | MEDLINE | ID: mdl-15692088

ABSTRACT

Vascular calcification develops within atherosclerotic lesions and results from a process similar to osteogenesis. One of the paracrine regulators of bone-derived osteoblasts, insulin-like growth factor-I (IGF-I), is also present in atherosclerotic lesions. To evaluate its possible role in vascular calcification, we assessed its in vitro effects on proliferation and differentiation in calcifying vascular cells (CVCs), a subpopulation of bovine aortic medial cells. Results showed that IGF-I inhibited spontaneous CVC differentiation and mineralization as evidenced by decreased alkaline phosphatase (AP) activity and decreased matrix calcium incorporation, respectively. Furthermore, IGF-I inhibited the AP activity induced by bacterial lipopolysaccharide, TNF-alpha, or H2O2. It also induced CVC proliferation based on 3H-thymidine incorporation. Results from Northern analysis and tests using IGF-I analogs suggest that IGF-I effects are mediated through the IGF-I receptor. IGF-I also activated both the extracellular signal-regulated protein kinase (ERK) and phosphatidylinositol 3-kinase (PI3K) pathways. Inhibition of either the ERK or PI3K pathway reversed IGF-I effects on CVC proliferation and AP activity, suggesting a common downstream target. Overexpression of ERK activator also mimicked IGF-I inhibition of lipopolysaccharide-induced AP activity. These results suggest that IGF-I promotes proliferation and inhibits osteoblastic differentiation and mineralization of vascular cells via both ERK and PI3K pathways.


Subject(s)
Aorta/cytology , Aortic Diseases/physiopathology , Calcinosis/physiopathology , Extracellular Signal-Regulated MAP Kinases/physiology , Insulin-Like Growth Factor I/pharmacology , Osteoblasts/drug effects , Phosphatidylinositol 3-Kinases/physiology , Signal Transduction/drug effects , Tunica Media/cytology , Alkaline Phosphatase/analysis , Animals , Becaplermin , Calcium/metabolism , Cattle , Cell Differentiation/drug effects , Cell Division/drug effects , Cells, Cultured/drug effects , Chromones/pharmacology , DNA-Binding Proteins/physiology , Extracellular Matrix/metabolism , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Flavonoids/pharmacology , Humans , Insulin-Like Growth Factor I/genetics , Insulin-Like Growth Factor I/physiology , Lipopolysaccharides/pharmacology , MAP Kinase Kinase Kinases/genetics , MAP Kinase Kinase Kinases/physiology , Morpholines/pharmacology , Osteoblasts/pathology , Platelet-Derived Growth Factor/pharmacology , Protein Serine-Threonine Kinases/physiology , Proto-Oncogene Proteins/physiology , Proto-Oncogene Proteins c-akt , Proto-Oncogene Proteins c-sis , Receptor, IGF Type 1/drug effects , Receptor, IGF Type 1/physiology , Recombinant Proteins/pharmacology , Signal Transduction/physiology , Transcription Factors/physiology , Transfection , Tumor Necrosis Factor-alpha/pharmacology , ets-Domain Protein Elk-1
SELECTION OF CITATIONS
SEARCH DETAIL
...